Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 & FLU A/B Test, and LumiraDx SARS-CoV-2 & RSV Test at Point of Care Testing Sites

NCT05268939 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.

NCT NCT05268939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05268939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 & FLU A/B Test, and LumiraDx SARS-CoV-2 & RSV Test at Point of Care Testing Sites
Lead sponsor
LumiraDx UK Limited
Phase
Observational
Overall status
Completed
Start date
January 4, 2022
Completion date
March 14, 2023
Enrollment
589 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza a, influenza type b, rsv infection